A prospective translational study investigating the association of gut microbiome (GM) diversity with pathological complete response (pCR) after neoadjuvant treatment in early stage rectal and esophageal cancers.

Authors

null

Ronan Andrew Mc Laughlin

Beaumont RCSI Cancer Centre, Dublin, Ireland;

Ronan Andrew Mc Laughlin , Ciaran Devoy , carolyn moloney , Kathleen Bennett , David Mcmahon , Michael R Conroy , Orla Fitzpatrick , Keith Egan , William Grogan , Oscar S. Breathnach , Patrick G. Morris , Adrian Gerard Murphy , Jarushka Naidoo , Mark Tangney , Bryan T. Hennessy

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Translational Research

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr TPS819)

DOI

10.1200/JCO.2023.41.4_suppl.TPS819

Abstract #

TPS819

Poster Bd #

P9

Abstract Disclosures